Science and Research

Omicron-induced interferon signaling prevents influenza A H1N1 and H5N1 virus infection

Recent findings in permanent cell lines suggested that SARS-CoV-2 Omicron BA.1 induces a stronger interferon response than Delta. Here, we show that BA.1 and BA.5 but not Delta induce an antiviral state in air-liquid interface cultures of primary human bronchial epithelial cells and primary human monocytes. Both Omicron subvariants caused the production of biologically active types I (α/β) and III (λ) interferons and protected cells from super-infection with influenza A viruses. Notably, abortive Omicron infection of monocytes was sufficient to protect monocytes from influenza A virus infection. Interestingly, while influenza-like illnesses surged during the Delta wave in England, their spread rapidly declined upon the emergence of Omicron. Mechanistically, Omicron-induced interferon signaling was mediated via double-stranded RNA recognition by MDA5, as MDA5 knockout prevented it. The JAK/STAT inhibitor baricitinib inhibited the Omicron-mediated antiviral response, suggesting it is caused by MDA5-mediated interferon production, which activates interferon receptors that then trigger JAK/STAT signaling. In conclusion, our study (1) demonstrates that only Omicron but not Delta induces a substantial interferon response in physiologically relevant models, (2) shows that Omicron infection protects cells from influenza A virus super-infection, and (3) indicates that BA.1 and BA.5 induce comparable antiviral states.

    • Bojkova, D.
  • Bechtel, M.
  • Rothenburger, T.
  • Kandler, J. D.
  • Hayes, L.
  • Olmer, R.
  • Martin, U.
  • Jonigk, D.
  • Ciesek, S.
  • Wass, M. N.
  • Michaelis, M.
  • Cinatl, J., Jr.
  • Keywords

      • Humans
  • *Influenza A Virus, H5N1 Subtype
  • *Influenza, Human
  • *Influenza A Virus, H1N1 Subtype
  • *covid-19
  • SARS-CoV-2
  • *Influenza A virus
  • Interferons
  • Antiviral Agents
  • *Janus Kinase Inhibitors
  • Ba.1
  • Ba.5
  • Covid-19
  • Delta
  • antiviral state
  • influenza
  • interferon
  • monocytes
  • super-infection
  • Publication details
    DOI: 10.1002/jmv.28686
    Journal: J Med Virol
    Pages: e28686 
    Number: 3
    Work Type: Original
    Location: BREATH
    Disease Area: PALI
    Partner / Member: MHH
    Access-Number: 36938992

    DZL Engagements

    chevron-down